VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2

The von Hippel-Lindau (VHL) is deficient in ∼70% of clear-cell renal cell carcinomas (ccRCC), which contributes to the carcinogenesis and drug resistance of ccRCC. Here we show that VHL-deficient ccRCC cells present enhanced cytotoxicity of anthracyclines in a hypoxia-inducible factor-independent ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yao-Hui, Wu, Zhao-Xia, Xie, Li-Qi, Li, Cai-Xia, Mao, Yu-Qin, Duan, Yan-Tao, Han, Bing, Han, San-Feng, Yu, Yun, Lu, Hao-Jie, Yang, Peng-Yuan, Xu, Tian-Rui, Xia, Jing-Lin, Chen, Guo-Qiang, Wang, Li-Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481740/
https://www.ncbi.nlm.nih.gov/pubmed/28643803
http://dx.doi.org/10.1038/ncomms15337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481740/
https://www.ncbi.nlm.nih.gov/pubmed/28643803
http://dx.doi.org/10.1038/ncomms15337

Ejemplares similares